Cargando…
Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction?
In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an i...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689480/ https://www.ncbi.nlm.nih.gov/pubmed/19435475 http://dx.doi.org/10.1186/cc7756 |
_version_ | 1782167800885805056 |
---|---|
author | Steil, Garry M Agus, Michael SD |
author_facet | Steil, Garry M Agus, Michael SD |
author_sort | Steil, Garry M |
collection | PubMed |
description | In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an increase in insulin resistance leading to beta-cell exhaustion, or a negative impact of exogenous glucocorticoid therapy, may be equally likely. |
format | Text |
id | pubmed-2689480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26894802010-04-03 Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? Steil, Garry M Agus, Michael SD Crit Care Commentary In the recent study by Preissig and Rigby in Critical Care, the authors argue that critical illness hyperglycemia in children with both respiratory failure and cardiovascular failure is due to a primary failure of the beta-cell. However, alternative explanations that the failure is secondary to an increase in insulin resistance leading to beta-cell exhaustion, or a negative impact of exogenous glucocorticoid therapy, may be equally likely. BioMed Central 2009 2009-04-03 /pmc/articles/PMC2689480/ /pubmed/19435475 http://dx.doi.org/10.1186/cc7756 Text en Copyright © 2009 BioMed Central Ltd |
spellingShingle | Commentary Steil, Garry M Agus, Michael SD Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title | Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title_full | Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title_fullStr | Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title_full_unstemmed | Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title_short | Critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
title_sort | critical illness hyperglycemia: is failure of the beta-cell to meet extreme insulin demand indicative of dysfunction? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689480/ https://www.ncbi.nlm.nih.gov/pubmed/19435475 http://dx.doi.org/10.1186/cc7756 |
work_keys_str_mv | AT steilgarrym criticalillnesshyperglycemiaisfailureofthebetacelltomeetextremeinsulindemandindicativeofdysfunction AT agusmichaelsd criticalillnesshyperglycemiaisfailureofthebetacelltomeetextremeinsulindemandindicativeofdysfunction |